disregardeverythingisay-blog - Tumblr blog

disregardeverythingisay-blog · 9 years

Text

3-MeO-PCMo, broken down and described

Dosage (oral) Threshold: 100mg Light: 100 - 300mg Common: 300 - 600mg Strong: 600 - 900mg Heavy: 900mg +

Duration (oral) Total duration: 5 - 6 hours Onset: 1 - 2 hours Peak: 2 - 3 hours Come down: 1 - 2 hours After effects: 2 - 3 hours

3-MeO-PCMo (4-[1-(3-methoxyphenyl)cyclohexyl]morpholine) is a new morpholine analogue of 3-MeO-PCP. It is a dissociative NMDA receptor antagonist and anesthetic drug of the arylcyclohexylamine chemical class with a potency of less than 1/10th of that of 3-MeO-PCP.

This compound induces a state referred to as "dissociative anesthesia" when ingested and is therefore used as a recreational drug. 3-MeO-PCMo has recently become freely available through online research chemical vendors[1] where it is being sold as a designer drug.

Although very little is known about this compound, similar morpholine analogues of phencyclidine have been researched before.[2][3]

In terms of its chemistry, 3-MeO-PCMo, or 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine, is classified as an arylcyclohexylamine drug. Ayrlcyclohexylamine drugs are named for their structures which include a cyclohexane ring bound to an aromatic ring along with an amine group at the same location. The aryl substituent of 3-MeO-PCMo is a phenyl ring with a methoxy (CH3-O-) substituent at R3, which is bound to a six-membered cyclohexyl ring. Bound at the same location on the cyclohexyl ring R1 is an amine group which is incorporated into a morpholine ring as R4. Morpholine is a six-membered heterocyclic ring with an oxygen subsitutent at R1. 3-MeO-PCMo is a morpholine analogue to 3-MeO-PCP, which lacks an oxygen moiety in its six-membered amine ring (a piperidine ring instead of a morpholine ring).

In terms of its pharmacology, due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based on its structure and subjective effect similarities to other arylcyclohexylamine dissociatives such as 3-MeO-PCP, PCP and MXE. With this in mind, 3-Meo-PCMo is thought to act as an NMDA receptor antagonist. NMDA receptors allow for electrical signals to pass between neurons in the brain and spinal column; for the signals to pass, the receptor must be open. NMDA receptor antagonists close the NMDA receptors by blocking them. This disconnection of neurons leads to loss of feeling, difficulty moving, and eventually the famous “hole.”

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical effects:

The subjective physical effects of 3-MeO-PCMo can be broken down into several components which progressively intensify proportional to dosage. These are described below and generally include:

Spontaneous tactile sensations - The 3-MeO-PCMo body high is a soft, warm, motionless and pleasurable tingling sensation which is all-encompassing across the body and not location specific to any area.

Decreased bodily weight - This creates the sensation that the body is floating and has become entirely weightless. This effect is strangely stimulating and encourages physical activities at low to moderate doses by making the body feel light and effortless to move.

Nausea - It's worth noting that high dose 3-MeO-PCMo trips can sometimes result in nausea and vomiting at the peak of the trip. For most people, this is surprisingly not as unpleasant as they would initially expect due to the accompanying detachment from the physical senses.

Motor control loss - A loss of gross and fine motor control alongside of balance and coordination is prevalent within 3-MeO-PCMo and becomes especially strong at higher doses. This means that one should be sitting down before the onset (unless experienced) in case of falling over and injuring oneself.

Physical euphoria

Tactile disconnection

Tactile suppression

Physical autonomy

Cognitive effects:

The general head space of 3-MeO-PCMo is often described as simplistic and shallow in comparison to that of MXE and ketamine. The specific cognitive effects can be broken down into several separate subcomponents which are listed and described below:

Depersonalization

Derealization

Consciousness disconnection

Memory suppression (ego death)

Thought deceleration

Immersion enhancement

Information processing suppression

Time distortion

Euphoria

Introspection

Déjà vu

Conceptual thinking

Anxiety suppression

Disinhibition

Amnesia

Visual effects:

Suppressions:

This substance does not enhance visual stimuli; instead, it tends to degrade and decrease visual aptitude in a variety of ways which generally include:

Visual disconnection - This eventually results in the 3-MeO-PCMo equivalent of the famous "k-hole" or, more specifically, holes, spaces and voids alongside of structures.

Double vision - This component is prevalent at moderate to heavy doses and makes reading impossible unless one closes an eye.

Pattern recognition suppression - This effect generally occurs at higher doses and makes one unable to recognize and interpret perceivable visual data.

Visual acuity suppression

Distortions:

Perspective distortions

Geometry:

The visual geometry found within 3-MeO-PCMo can be described as very dark and bland when compared to that of ketamine or DXM. It often consists of many tiny interlocking and woven lines. It does not extend beyond level 4 geometry and can be comprehensively described through its variations as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicoloured in scheme, glossy in shading, soft in edges, small in size, slow in speed, smooth in motion, equal in rounded and angular corners, immersive in depth and consistent in intensity.

Auditory effects:

Suppression

Distortions

Hallucinations

Physical health effects, potential addiction and tolerance:

The toxicity and long-term health effects of recreational 3-MeO-PCMo use have not been studied in any scientific context and the exact toxic dose is unknown. This is because 3-MeO-PCMo is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried 3-MeO-PCMo within the psychonaut community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

There is a tolerance build up with 3-MeO-PCMo which results in the need to consume increasingly large doses in order to achieve the same level of effects. This should reset to baseline after 1 - 2 weeks. There may be some addictive potential, but this is still unknown.

In terms of its long-term health effects when used repeatedly and with excess for extended periods of time, 3-MeO-PCMo seems to exhibit almost identical bladder and urinary tract problems to those found within ketamine, MXE and other arylcyclohexylamines, but to an even more extreme extent. This is because 3-MeO-PCMo is 50% less potent than that of ketamine which means significantly more of the drug must be consumed in order to achieve the same effects. Symptoms of 3-MeO-PCMo-induced cystitis can become extremely serious and can be described as:

Urinary frequency - Urinary frequency is the need to empty the bladder every few minutes.

Urinary urgency - This can be described as a sudden and compelling need to urinate.

Urinary pressure - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination.

Pelvic and bladder pain - Pain can develop suddenly and severely, particularly as the bladder fills with urine.

Hematuria - Hematuria is visible blood in the urine.

Incontinence - This is the leakage of urine.

All of these, however, can easily be avoided by simply not using 3-MeO-PCMo on a daily or even weekly basis and manually limiting one's usage of the substance.

Legal issues:

3-MeO-PCMo is currently a legal grey area drug worldwide and is freely available through the use of online research chemical vendors. However, this does not guarantee anyone to be immune from legal prosecution should they be found in possession of this substance as the legality is likely to vary from country to country.

Within the U.K. specifically, as 3-MeO-PCMo is the morpholine analogue of 3-MeO-PCP, it is therefore an arylcyclohexylamine (ACH) that is not controlled in the U.K. because a morpholine substituion on the amine is not proscribed by the country's generic ACH laws.

Conclusion:

3-MeO-PCMo is by far the closest experience to that of MXE or ketamine currently available in the U.K. legal research chemical market. Its absurd lack of potency, however, makes it unusable for regular usage due to its proportionally adverse effects on the bladder.

This substance breakdown was written through collaboration between PsychonautWiki contributors Kaylee, Josikins and Oscarette. The full article is available here.

16 notes · View notes

disregardeverythingisay-blog · 9 years

Text

Ephenidine, broken down and described

Dosage (oral) Threshold: 50 - 75mg Light: 75 - 110mg Common: 110 - 150mg Strong: 150 - 200mg Heavy: > 200mg +

Duration (oral) Total duration: 5 - 7 hours Onset: 10 - 30 minutes

Ephenidine (N-Ethyl-1,2diphenylethylamine) is a dissociative NMDA receptor antagonist and anesthetic drug of the phenethylamine chemical class. It has similar effects to that of the arylcyclohexylamine and morphinan classes of dissociatives.

This compound induces a state referred to as "dissociative anesthesia" and is used as a recreational drug. Very little is known about this substance, but it has recently become freely available through online research chemical vendors where it is being sold as a designer drug. Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based on its structure and subjective effect similarities to other piperidine dissociatives such as diphenidine and methoxphenidine.

In terms of its chemistry, ephenidine is a molecule of the diarylethylamine class. It contains a substituted phenethylamine skeleton with an additional phenyl ring bound to Rα. An ethyl chain is bound to the terminal amine RN of the phenethylamine. Ephenidine is structurally analogous to diphenidine and MXP, but is not a piperidine dissociative. Ephenidine shares a diphenylethylamine skeleton with diphenidine and MXP, but lacks a piperidine substitution.

In terms of its pharmacology, no formal studies have been carried out. However, ephenidine is thought to act as an NMDA receptor antagonist due to its structural similarities to diphenidine. NMDA receptors allow for electrical signals to pass between neurons in the brain and spinal column; for the signals to pass, the receptor must be open. NMDA receptor antagonists close the NMDA receptors by blocking them. This disconnection of neurons leads to loss of feeling, difficulty moving, and eventually the famous “hole.” This compound induces considerable stimulation at higher doses which suggests that it might function as a serotonin, dopamine and noradrenaline reuptake inhibitor in a similar manner to other dissociatives.

Physical effects:

The subjective physical effects of ephenidine can be broken down into several components which progressively intensify proportional to dosage. These are described below and generally include:

Tactile disconnection

Spontaneous tactile sensations - The ephenidine body high is a soft and pleasurable tingling sensation which is motionless and all-encompassing with no specific location.

Stimulation - This compound provides stimulating effects at lower dosages which are less intense than that of diphenidine or methoxphenidine.

Tactile suppression - This partially to entirely suppresses one's sense of touch, creating feelings of numbness within the extremities. It is responsible for the anaesthetic properties of this substance.

Motor control loss - A loss of gross and fine motor control alongside of balance and coordination is prevalent within the ephenidine experience and becomes especially strong at higher doses. This means that one should be sitting down before the onset (unless one is experienced) in case of falling over and injuring oneself.

Physical autonomy

Increased heart rate

Cognitive effects:

The general head space of ephenidine is often described as particularly euphoric and clear-headed in comparison to that of DXM and ketamine. The specific cognitive effects can be broken down into several separate subcomponents which are listed and described below:

Depersonalization

Derealization

Consciousness disconnection

Memory suppression (ego death)

Thought deceleration

Information processing suppression

Time distortion

Euphoria

Introspection

Déjà vu

Conceptual thinking

Compulsive redosing

Anxiety suppression

Disinhibition

Amnesia

Unity and interconnectedness

Visual effects:

Suppressions:

This substance does not enhance visual stimuli; instead, it tends to degrade and decrease visual aptitude in a variety of ways which generally include:

Visual disconnection - This eventually results in the ephenidine equivalent of the famous "k-hole" or, more specifically, holes, spaces and voids alongside of structures. However, it is worth noting that particularly heavy dosages must be consumed to reach the deepest state of this component in comparison to other more classical dissociatives such as ketamine or methoxetamine.

Visual acuity suppression

Double vision - This component is prevalent at moderate to heavy dosages and makes reading impossible unless one closes an eye.

Pattern recognition suppression - This effect generally occurs at higher dosages and makes one unable to recognize and interpret perceivable visual data.

Distortions:

Ephenidine exhibits a full array of dissociative distortions and alterations in visual perception which generally includes:

Drifting (melting, flowing, breathing and morphing) - In comparison to other dissociatives, this effect is more prominent than ketamine, MXE, diphenidine and methoxphenidine. The visual drifting is simplistic, slow and smooth in motion, static in appearance and unrealistic/cartoon-like in style.

Perspective distortions

Scenery slicing

Geometry:

The visual geometry found within ephenidine can be described as very distinct and psychedelic when compared to that of ketamine, MXE, methoxphenidine and diphenidine. It is considerably less detailed than that of DXM. It does not extend beyond level 5 and can be comprehensively described through its variations as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicoloured in scheme, glossy in shading, soft in edges, small in size, slow in speed, smooth in motion, equal in rounded and angular corners, immersive in depth and consistent in intensity.

Hallucinatory states:

At high doses, ephenidine can produce a full range of high level hallucinatory states in a fashion that is less consistent and reproducible than that of many other commonly used psychedelics. These effects include:

Internal hallucinations (autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots) - In comparison to other dissociatives, this effect can occur at heavy dosages, but is considerably less common than the same effect found within psychedelics and deliriants. It can be comprehensively described through its variations as delirious in believability, fixed in style, equal in new experiences and memory replays in content, autonomous in controllability and solid in style.

Auditory effects:

The auditory effects are common in their occurrence and exhibit a range of effects which commonly includes:

Enhancements

Suppression

Distortions

Hallucinations

Physical health effects, potential addiction and tolerance:

The toxicity and long-term health effects of recreational ephenidine use have not been studied in any scientific context and the exact toxic dosage is unknown. This is because ephenidine is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried ephenidine within the psychonaut community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

There is a very strong tolerance build up with ephenidine which results in the need to consume increasingly large doses in order to achieve the same level of effects. This should reset to baseline after 1 - 2 weeks. There may be some addictive potential, but this is still unknown.

Legal issues:

Ephenidine is currently a legal grey area drug worldwide and is freely available through the use of online research chemical vendors. However, this does not guarantee anyone to be immune from legal prosecution should they be found in possession of this substance as the legality is likely to vary from country to country.

Conclusion:

In conclusion, ephenedine is a deeply profound dissociative which presents a full range of effects at high enough doses. Although it is not an MXE replacement, it is perhaps the best novel dissociative to recently arrive on the legal research chemical scene and is superior to that of diphenidine or MXP in my opinion.

This substance breakdown was written through collaboration between PsychonautWiki contributors Kaylee, PJosepherum, Josikins and Oscarette. The full article is available here.

25 notes · View notes

disregardeverythingisay-blog · 9 years

Photo

Hey there, depending on how closely you follow this project you may be aware that this website is simply the smaller scale blog to our much bigger project known as PsychonautWiki.

I have recently set up a Patreon page for PsychonautWiki to potentially help mitigate our progressively more expensive server costs.

If this website has made a difference to your life and you enjoy reading it, donations of any size are sincerely appreciated and go directly towards the hosting of our expensive server, producing its content and furthering the cause. So if you are feeling kind then please click the image above and consider becoming a patreon by pledging as little as $1 per month. Every little helps!

Thank you so much in advance <3 <3

#psychonaut #psychedelic #deis #disregardeverythingisay #patreon #replication #replications #psychonauts #thank you i love you

23 notes · View notes

disregardeverythingisay-blog · 9 years

Text

DMT extraction using sodium hydroxide and naphtha

Introduction:

The guide below is a recipe for extracting homemade DMT using freely accessible ingredients which can be purchased in stores or online. It is provided for informational and educational purposes only. We do not encourage you to break the law and are not responsible for your actions.

This DMT extraction was written by PsychonautWiki administrator Kaylee before being edited and proofread by Oscarette. For more information and larger pictures of this extraction process, please see our full article here. For information on DMT and its effects, please click here.

Objective:

Acacia confusa root bark contains up to 1.15% DMT/N,N-Dimethyltryptamine. [1] If the steps of this extraction are followed precisely on 500g of acacia root bark, you can expect a maximum theoretical yield of 5.75g of DMT. Experimental yields are highly dependent on adherence to procedure, hence this extraction can produce a range of 0g - 4.5g. It is recommended to run a test extraction on a lesser amount of acacia confusa root bark, such as 200g. With experience, as one becomes familiar with the process, the extraction will produce higher yields.

Safety:

Naphtha (DANGER: Extremely flammable) - Naphtha is a petroleum solvent comparable in strength to paint thinner, but more volatile. Naphtha has a low flash point, making it highly flammable; it behaves similarly to lighter fluid. Naphtha is harmful if it is inhaled, swallowed, or if the liquid is aspirated into the lungs. Naphtha is an irritant to the eyes and skin. In the event of skin contact, washing your hands with soap will prevent irritation. Excessive inhalation can cause negative health effects. Naphtha can be handled safely, but should not be inhaled or swallowed. To prevent exposure, allow the DMT to fully dry. Naphtha can be found in USA hardware or paint stores (e.g. VM&P Naphtha.) [2]

Sodium Hydroxide (also known as lye or caustic soda) - Sodium hydroxide is very hazardous in case of skin or eye contact, ingestion, or respiration. Eye contact can result in corneal damage or blindsides while skin contact can produce inflammation and blistering. Exposure can result in chemical burns because sodium hydroxide solutions can readily decompose proteins and lipids in body tissues via hydrolysis. Exposure will leave the skin feeling soapy and will not immediately damage the skin. Wash hands thoroughly if this soapy sensation or irritation is felt. Wear gloves and protective eye wear when handling this substance. Repeated or prolonged exposure can be toxic. When sodium hydroxide is added to the glass jar, it must be done gradually to prevent the strong exothermic reaction that will crack the container. Sodium hydroxide is deliquescent and readily absorbs moisture from the air, so you should keep the container sealed. Sodium hydroxide can be found in USA hardware stores sold as Red Devil Lye. [3]

Theory:

This extraction uses a traditional acid-base methodology to extract freebase DMT. The first steps (the acid wash using vinegar and water) acidify the solution to a pH of 4. Vinegar reacts with the DMT in the plant material to create DMT acetate; this stage is often called the de-fat. Converting DMT to a salt form allows for easier absorption by the polar solution. Basifying the solution to a pH of 13 in the following steps allows it to be extracted from the polar solution (water) to the nonpolar solution (naptha). The basic solution reacts with DMT acetate through deprotonation to produce the pure basic form of DMT (the freebase). A high pH solution reduces solubility of DMT. When naphtha is added, the DMT transfers into this nonpolar solution layer. DMT is virtually insoluble in this aqueous phase, so it precipitates out of the naphtha solution via crystallization when kept at freezing temperatures.

Reagents/Materials:

Naptha

Lye/Sodium Hydroxide (NaOH)

Acacia confusa root bark (shredded)

Vinegar

2L glass container

2 large pots

Turkey baster (glass)

Chemical resistant gloves

Safety goggles

Stove

Optional:

Funnel

PH meter

Note: The measurements given are meant for an extraction using 500g acacia confusa root bark. They can be scaled up or down if running an extraction on a different amount of root bark. One can adjust the quantity of reagents used in this extraction proportionally with the amount of root bark used. For example, to extract 100g of root bark one would scale the proportions of the other materials accordingly to 20% of their original amounts. Do not scale down duration in steps such as cooking time in step 2; only scale the quantity of reagents.

Preparation:

If possible, purchase shredded acacia confusa root bark. If you cannot obtain this, use a coffee grinder or blender to shred the bark into fine pieces. However, a coffee grinder will not be sufficient for large root bark pieces. Hence it is advisable to purchase the bark shredded. Using shredded bark has a large impact on extraction yields. Finely shredded or powdered bark results in higher surface area for the chemical reactions to occur.

Freeze the root bark, then let it thaw out. Repeat this three times. Freezing and thawing causes the plant cells to undergo lysis. Lysis is the destruction of the cell wall and membrane, resulting in the disintegration of the cell. Decomposing the cell membrane allows for higher absorption of DMT from the plant matter in the following steps.

Procedure:

1. In a large pot (pot A), add 1800mL of water and 200mL of vinegar. This brings the pH of the solution to approximately 4. This will convert the DMT in the plant material in its acid salts (which are soluble in water). Most other alkaloids from the plant material are not soluble and will not be absorbed by the solution. This step helps remove impurities by separating the DMT from other plant alkaloids. These other alkaloids are not physically harmful, but lower purity results in an increased body load. Add the 500g of root bark, then boil with a lid on the pot for at least an hour and 30 minutes. This gives sufficient time to separate the DMT from the plant material.

2. Strain the solution into another large pot (pot B). Refill pot A with 1800mL of water and 200mL of vinegar, then add the root bark back into pot A. Boil for another cycle of an hour and 30 minutes. The desired end result is 1000mL (but some excess is fine).

3. Repeat step 2 one more time. Repeatedly transferring the solution to pot B and adding fresh water and vinegar to pot A encourages increased reaction of DMT with the solution. This helps prevent the reaction from reaching equilibrium with the solution, causing more DMT to react out of the plant material.

4. Now, reduce the contents of pot B (a total of somewhere around 4000mL) down to 1200mL by boiling without a lid. The liquid should now be a rusty red color while it is hot. This process will take approximately 40 minutes. Reducing the volume of liquid at this stage increases the concentration of DMT within the solution by evaporation. This serves to make the following steps easier by requiring less reagents.

5. Allow the liquid in pot B to cool, then pour it into a 2L glass container and allow it to completely cool in the refrigerator. This will take at least two hours. Allowing the liquid to cool helps prevent excess heat from the sodium hydroxide reaction from damaging the jar in the following steps.

6. For the following steps, take appropriate safety precautions and wear safety goggles and chemical resistant gloves. Sodium hydroxide can cause chemical burns and blindness. Maximum care should be taken while handling.

7. Weigh out 120 grams of sodium hydroxide. Slowly add it in small increments to the solution in the glass container. The contents of the container will heat up rapidly with the addition of the sodium hydroxide. It is important to add it slowly to prevent the glass container from exploding from the exothermic reaction. A safe guideline is adding 20g every 2 minutes and stirring in between. The contents will turn grey then black as the pH increases. This step aims to reach a pH of 13; at this pH level, the solution will be black. This step converts DMT into its freebase form, which can be extracted with naphtha.

7a. (Optional) Measure the pH of the solution with a pH meter. For ideal results, the solution should reach a pH of 13.

8. The contents of the jar should still be warm from the previous step. If not, double boil the jar to warm the solution. To do this, fill a large pot with water and bring it to a boil. Now, hold the jar suspended in the boiling water. Keep the jar suspended in the boiling water so that it doesn't touch the bottom of the pot. A double boil allows even heat distribution by heating through contact with the water surrounding the jar instead of heating it through contact with the bottom of the pot. Then add 500mL of naphtha to the jar and seal it.

9. Shake vigorously for 3 minutes and then let the contents separate for 10 minutes. Repeat this step 4-5 times, keeping the jar contents warm. Shaking the jar encourages maximum dispersion of its contents; this allows more DMT freebase to be pulled into the naphtha layer.

10. Now allow the naphtha layer to separate fully. This may take up to several hours.

11. Using a glass turkey baster, carefully transfer the top naphtha layer into an appropriately sized crystallization jar. Avoid transferring any of the black basic layer. Error on the side of caution as it is preferable to prevent contamination by leaving the remnant of the naphtha layer. It can be difficult to prevent contamination as the naphtha layer left in the solution jar is transferred. A wide mouth jar for crystallization will be easier to scrape the DMT from.

12. Place the jar into the freezer for at least 48 hours. The DMT will gradually precipitate out of the naphtha solution. 72 hours gives ample time for it to crystallize completely. DMT is insoluble in the naphtha solution at low temperatures so it precipitates out. If the naphtha solution is left at room temperature before the DMT is separated from it, the DMT can potentially dissolve back into the naphtha.

13. To separate the DMT from the naphtha solution, pour the contents of the crystallization jar through a funnel with a pipe screen or coffee filter. Allow the extracted DMT to dry for ten hours. It will dry into powdery crystal or a waxy consistency based on the purity of the extraction. The remaining naphtha can be reused in additional pulls. Steps 7-13 can be repeated about 5 times for decent yields. A pull can result in 200mg-1g of DMT dependent on the success of the extraction. Using pH strips and accurate/sufficient equipment is beneficial to increase yields.

#dmt #dimethyltryptamine #tryptamine #psychedelic #psychedelics #dmt extraction #psychonaut #psychonauts #psychonautics #kaylee is awesome and we love her

297 notes · View notes

disregardeverythingisay-blog · 10 years

Text

1P-LSD, broken down and described

Dosage (oral) Threshold: < 20 µg Light: 25 - 75 µg Common: 50 – 150 µg Strong: 150 – 400 µg Heavy: > 400 µg

Duration (oral) Total duration: 8 - 10 hours Onset: 30 minutes - 2 hours Peak: 2 - 5 hours Come down: 2 - 4 hours After effects: > 2 hours

1-propionyl-lysergic acid diethylamide (abbreviated as 1P-LSD or 1P-LAD) is a hallucinogenic psychedelic drug of the lysergamidefamily.

This substance has little to no history of human usage. It has not been reported upon within any formal scientific literature and is almost entirely unknown by both the academics and public. However, given its similarity to LSD and ALD-52, the structural similarity reliably suggests an extremely similar effect profile. Due to the lack of research regarding the substance, all discussion regarding the pharmacology of it is purely based on its structure and subjective effect similarities to other lysergamides.

Over the first few months of 2015, it came to be marketed as a legal alternative to LSZ, AL-LAD and LSD through online research chemical vendors which are currently selling the compound in the form of freely available blotter sheet tabs. It is usually marketed as a research chemical which means that it is sold legally but not meant for human consumption.

In terms of its chemistry, 1P-LSD is a member of the lysergamide family and is generally regarded as a psychedelic. It is analogous to LSD, featuring a propionyl group bound to the nitrogen of the indole group. It is homologous to ALD-52, which contains an acetyl group instead of the propionyl group bound to the same location.

In terms of its pharmacology, 1P-LSD acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from 1P-LSD's efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

It has been theorized that 1P-LSD may be a prodrug to LSD. Despite this prevailing theory, however, it appears that this is likely untrue. It has both a shorter duration, subtly distinct subjective effects and an extremely close potency which are three things which are rarely associated with a prodrug (especially in combination).

The effects of 1P-LSD are almost identical to that of its close structural relative LSD with the differences being so minuscule they are almost negligible or primarily due to different responses within the tripper.

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely if ever occur all at once but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical effects:

The physical effects of 1P-LSD can be broken down into several components all of which progressively intensify proportional to dosage. These are described below and generally include:

Spontaneous tactile sensations - The "body high" of 1P-LSD can be described as proportionally very intense in comparison to its accompanying visual and cognitive effects. It behaves as a euphoric, fast moving, sharp and location specific tingling sensation. For some, it is manifested spontaneously at different unpredictable points throughout the trip, but for most it maintains a steady presence that rises with the onset and hits its limit once the peak has been reached. At moderate to high doses of 1P-LSD, this sensation will usually hit its highest level and become so overwhelming that people may find themselves writhing on the floor in complete pleasure.

Stimulation - In terms of its effects on the physical energy levels of the tripper, 1P-LSD is usually considered to be very energetic and stimulating without being forced. For example, when taken in any environment it will usually encourage physical activities such as running, walking, climbing or dancing. In comparison, other more commonly used psychedelics such as psilocin are generally sedating and relaxed.

Nausea - Mild nausea is occasionally reported when consumed in moderate to high dosages and either passes instantly once the tripper has vomited or gradually fades by itself as the peak sets in.

Tactile enhancement

Bodily control enhancement

Salivation

Increased heart rate

Pupil dilation

Cognitive effects:

The cognitive effects of 1P-LSD can be broken down into several components all of which progressively intensify proportional to dosage. In comparison to other psychedelics such as psilocin, LSA and ayahuasca, 1P-LSD is significantly more stimulating and fast paced in terms of the specific style of thought stream produced and contains a large number of potential effects.

The most prominent of these cognitive effects generally include:

Current mind state enhancement

Thought acceleration

Novelty enhancement

Time distortion

Analysis enhancement

Personal bias suppression

Conceptual thinking

Memory suppression (ego death)

Thought loops

Feelings of interdependent opposites

Delusions

Unity and interconnectedness

Feelings of self-design

Spirituality enhancement

Delineation of thought

Visual effects:

Enhancements

1P-LSD presents a full and complete array of visual enhancements which generally includes:

Visual acuity enhancement

Colour enhancement

Pattern recognition enhancement

Distortions

1P-LSD presents a full and complete array of visual distortions which generally includes:

Drifting (melting, breathing, morphing and flowing) - In comparison to other psychedelics, this effect can be described as highly detailed and cartoon-like in its appearance. The distortions are slow and smooth in motion and fleeting in their appearance.

Tracers

Depth perception distortions

Symmetrical texture repetition

Colour shifting

Perspective distortions

Geometry

The visual geometry that is present throughout this trip can be described as more similar in appearance to that of 2C-B or 2C-I than psilocin, LSA or DMT. It can be comprehensively described through its variations as primarily intricate in complexity, algorithmic in form, unstructured in organization, brightly lit, colourful in scheme, synthetic in feel, multicoloured in scheme, flat in shading, sharp in edges, large in size, fast in speed, smooth in motion, angular in its corners, non-immersive in depth and consistent in intensity.

In the case of higher level geometry, this substance is level 8A dominant but is also capable of inducing 8B Geometry under the right circumstances.

Hallucinatory states

1P-LSD is capable of producing a full range of low and high level hallucinatory states in a fashion that is significantly less consistent and reproducible than that of many other commonly used psychedelics. These effects include:

Transformations

Internal hallucinations (Autonomous entities, Settings, sceneries, and landscapes, Alterations in perspective and Scenarios and plots) - Although 1P-LSD is technically capable of producing hallucinatory states in a fashion that is on par with psilocin or DMT in its vividness and intensity, these effects are rarer and more inconsistent in comparison. While traditional psychedelics such as LSA, ayahuasca and mescaline will induce internal hallucinations near consistently at level 5 geometry and above, 1P-LSD will for most simply go straight into Level 8A visual geometry. This lack of consistently induced hallucinatory breakthroughs means that for most, 1P-LSD is not quite as deep of an experience as certain other psychedelics. On the occasion that they are induced, however, they can be comprehensively described in terms of their variations as lucid in believability, interactive in style, new experiences in content, autonomous in controllability and geometry-based in appearance.

Auditory effects:

The auditory effects of 1P-LSD are common in their occurrence and exhibit a full range of effects which commonly include:

Enhancements

Distortions

Hallucinations

Physical health effects, potential addiction and tolerance:

The toxicity and long term health effects of recreational 1P-LSD use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 1P-LSD is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychedelic community who have tried 1P-LSD suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

1P-LSD is non-habit forming and the desire to use it can actually decrease with use. It is most often self-regulating.

An almost immediate tolerance is built to 1P-LSD after ingestion, preventing one from experiencing its full effects more often than every 4-7 days unless they increase their dose significantly.

Legal issues:

1P-LSD is currently a grey area compound within all parts of the world. This means that it is not known to be specifically illegal within any country, but that people may still be charged for its possession under certain circumstances such as under analogue laws and with the intent to sell or consume.

Conclusion:

In conclusion, 1P-LSD is an exciting new research chemical with little to no information regarding its existence within the formal scientific literature. In terms of the effects it produces, it is identical to LSD apart from a slightly shorter duration and is therefore an excellent and worthwhile alternative which is superior to that of LSZ and AL-LAD.

This substance breakdown was written through collaboration between PsychonautWiki contributors Josikins and Oscarette. The full article (including references) is available here.

66 notes · View notes

disregardeverythingisay-blog · 10 years

Text

2C-C, broken down and described

Dosage (oral) Threshold : 5 - 10 mg Light : 10 – 30 mg Common : 30 – 50 mg Strong : 50 – 70 mg Heavy : 70+ mg

Duration (oral) Total duration : 4 - 6 hours Onset : 1 - 3 hours Peak : 2 - 3 hours Come down : 1 - 2 hours After effects : > 2 hours

2C-C (2,5-Dimethoxy-4-chlorophenethylamine) is a psychedelic phenethylamine of the 2C-x family.[1] It was first synthesized by Alexander Shulgin and described in his 1991 book PiHKAL: A Chemical Love Story.

In modern times, it is used as a recreational drug and an entheogen, rarely sold on the streets and almost exclusively obtained as a grey area research chemical through the use of online vendors. Therefore, it is relatively uncommon and has only a short history of human use.

Many users report that 2C-C is gentler and more sedating than other closely related psychedelic phenethylamines.

In terms of its chemistry, 2C-C is a substituted phenethylamine with methoxy groups attached to carbons R2 and R5 as well as a chlorine attached to carbon R4.

In terms of its pharmacology, 2C-C's psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Physical effects:

The physical effects of 2C-C can be broken down into 9 components all of which progressively intensify proportional to dosage. These are described below and generally include:

Spontaneous tactile sensations - The "body high" of 2C-C can be described as a pleasurable, warm, soft, all-encompassing and mild tingling sensation. This maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.

Stimulation and Sedation - In terms of its effects on the physical energy levels of the tripper, the 2C-C experience begins with mild stimulation, but usually becomes very sedating as the experience progresses and lacks the distinctive energetic feeling associated with most phenethylamines. This feeling was accurately described in Alexander Shulgin's PiHKAL as "an intense form of relaxation."

Nausea - Although nausea remains present, in comparison to other phenethylamines such as 2C-E, 2C-I or 2C-B, this remains extremely mild and dissipates quickly even with higher dosages. It is perhaps one of the most physically underwhelming psychedelics out there for this reason alone.

Bodily control enhancement and Motor control loss - Whilst at lower doses one may find that their bodily control is enhanced, at higher dosages it seems to become suppressed.

Tactile enhancement

Temperature regulation loss

Salivation

Increased heart rate

Cognitive effects:

The head space of 2C-C is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.

The total sum of these cognitive components regardless of the setting generally includes:

Analysis enhancement

Empathy, love and sociability enhancement - This component is consistently manifested only in the context of social settings in which one is within the company of others. These feelings of sociability, love and empathy are a little weaker and less sharp than those found on substances such as MDMA and 2C-B. They primarily manifest during the stimulating onset of the experience and dissipate once the full extent of the trip takes place.

Thought acceleration

Time distortion

Novelty enhancement

Sexual arousal

Conceptual thinking

Thought connectivity

Current mind state enhancement

Personal bias suppression

Memory suppression

Unity and interconnectedness

Visual effects:

Enhancements

2C-C presents a full and complete array of possible visual enhancements which generally includes:

Acuity enhancement

Colour enhancement

Pattern recognition enhancement

Distortions

2C-C presents a full and complete array of possible visual distortions which generally includes:

Drifting (melting, flowing, breathing and morphing) - In comparison to other psychedelics, this effect can be described as highly detailed, slow and smooth in motion, static in appearance and realistic in style.

Tracers

Colour shifting

Geometry

The visual geometry that is present throughout this trip can be described as more similar in appearance to that of 4-AcO-DMT or Ayahuasca than that of LSD, 2C-B or 2C-I. They can be comprehensively described as structured in their organization, organic in geometric style, intricate in complexity, large in size, slow and smooth in motion, colourful in scheme, glossy in colour, equally blurred and sharp in their edges and equally rounded and angular in their corners. They give off a contradictory natural and synthetic feel to them that at higher dosages. While the geometry for 2C-C has yet to be formally confirmed, it seems more likely to result in states of Level 8B visual geometry over Level 8A.

Hallucinatory states

2C-C produces a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. This holds particularly true in comparison to other substances within the phenethylamine family. These effects include:

Transformations

Internal hallucinations - In comparison to other psychedelics such as LSD, 2C-C is extremely high in hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

External hallucinations - 2C-C is capable of external hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They can be described as external in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

Machinescapes

Auditory effects:

The auditory effects of 2C-C are common in their occurrence and exhibit a full range of effects which commonly include:

Enhancements

Distortions

Hallucinations

Physical health effects, potential addiction and tolerance:

The toxicity and long term health effects of recreational 2C-C use do not seem to have been studied in any scientific context and the median lethal dose (LD50) is unknown. This is because 2C-C is a research chemical with very little history of human usage. Anecdotal evidence from those who have used 2C-C would suggest that there are little to no immediate or short-term negative health effects attributed to simply trying the drug at low to moderate doses or using it very sparingly. The validity of these statements, however, cannot be confirmed.

The addictive potential of 2C-C has not yet been formally studied, but anecdotal evidence would suggest that 2C-C is not physically addictive. Many users describe a self-regulating quality and commonly report a tolerance build up when using the drug consecutively many days in a row. A build up in tolerance may lead to weakened effects and a diminished experience, however, this effect is nearly non-existent when consumption periods are spaced 5-7 days apart.

Legal issues:

United States: 2C-C is listed in schedule I of section 202(c) of the Controlled Substances Act in the United States. This was signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.

United Kingdom: 2C-C is a class A controlled substance as it is covered by the phenethylamine derivatives clause of the Misuse of Drugs Act of 1971.

Sweden: 2C-C is classified as a "health hazard" as of March 1, 2005 in their regulation SFS 2005:26, making it illegal to sell or possess.

Japan: 2C-C is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.

Australia: Australia has a blanket ban over all substituted phenethylamines including the entire 2C-X family.

Conclusion:

Despite its lack of relative potency, 2C-C definitely holds up as an excellent psychedelic and is particularly useful for those who are inexperienced. Although I have yet to determine the proper dosage for this method, I would highly recommend smoking or vaporizing this compound using a standard water bong (like one used to smoke cannabis) as it delivers an intense experience which is somewhat on par with a phenethylamine-esque DMT breakthrough experience.

This substance breakdown was written through collaboration between PsychonautWiki contributors PJosepherum, Josikins and Oscarette. The full article, including references, is available here.

33 notes · View notes

disregardeverythingisay-blog · 10 years

Text

Diphenidine, broken down and described

Dosage (oral) Threshold : 50 mg Light : 70 – 85 mg Common : 85 – 110 mg Strong : 110 – 150 mg Heavy : >150 mg

Duration (oral) Total duration : 2 - 5 hours Onset : 15 - 30 minutes After effects : 4 - 24 hours

Diphenidine (1-(1,2-diphenylethyl)piperidine) is a dissociative NMDA receptor antagonist and anesthetic drug that has been sold online as a research chemical.

The synthesis of diphenidine was first reported in 1924 and employed a nitrile displacement reaction analogous to the one that would later be used to discover phencyclidine in 1956. Shortly after the 2013 UK ban on arylcyclohexylamines, diphenidine and the related compound methoxphenidine became available on the grey market. Anecdotal reports describe high doses of diphenidine producing "bizarre somatosensory phenomena and transient anterograde amnesia."

In 2014, there have been two published reports of diphenidine being sold in combination with synthetic cannabinoids in Japanese herbal incense blends. A herbal incense sold in the Shizuoka Prefecture under the name "Aladdin (sic) Spacial Edition" was found to contain diphenidine and 5-fluoro-AB-PINACA at concentrations of 289 mg/g and 55.5 mg/g, respectively. Another product called ‘‘Herbal Incense. The Super Lemon’’ containing AB-CHMINACA, 5F-AMB, and diphenidine was implicated in a fatal overdose.

Based on collaborative anecdotal evidence, diphenidine seems to have a much more rapid onset and lower half life when vaporized or smoked. When consumed this way, it is a suspected to be carcinogenic when excess heat is used. Some user reports have concluded that vaporization requires as low as 20% of what would be a common oral dose for that person.

In terms of its chemistry, diphenidine is a diarylethylamine related to methoxphenidine. It is named for its two phenyl and piperidine groups. Diphenidine's crystalline structure is very similar to MK-801 (Dizocilpine) and shares many of the same effects. These two compounds are homeomorphs. Diphenidine is synthesized in a reaction analogous to the synthesis of PCP. The (R)-enantiomer of diphenidine has a remarkable high affinity as a NMDA receptor channel blocker.

In terms of its pharmacology, diphenenidine acts as an NMDA receptor antagonist. NMDA receptors allow for electrical signals to pass between neurons in the brain and spinal column; for the signals to pass, the receptor must be open. NMDA receptor antagonists close the NMDA receptors by blocking them. This disconnection of neurons leads to loss of feeling, difficulty moving, and eventually the famous “hole”.

Although vendors of diphenidine have stated the compound acts as a dopamine-reuptake inhibitor and a serotonin reuptake inhibitor with µ-opioid affinity and typical dissociative effects, to date diphenidine has not been screened for affinity at the dopamine transporter. If this is indeed the case, however, it provides an explanation for its euphoric and often stimulating effects.

Diphenidine and related diarylethylamines have been studied in vitro as treatments for neurotoxic injury. Diphenidine may be a stronger NMDA receptor antagonist for neurogenis and neurological repair than other more common NMDA receptor antagonistic dissociatives such as ketamine, dextromethorphan, PCP analogs, Iboga and methoxetamine.

Physical effects:

The subjective physical effects of diphenidine can be broken down into nine components all of which progressively intensify proportional to dosage. These are described below and generally include:

Tactile disconnection

Spontaneous tactile sensations - The diphenidine body high is a sharp, pleasurable tingling sensation which is location specific to the hands, feet and head.

Tactile suppression - This partially to entirely suppresses one's own sense of touch, creating feelings of numbness within the extremities. It is responsible for the anaesthetic properties of this substance.

Physical autonomy

Motor control loss - A loss of gross and fine motor control alongside of balance and coordination is prevalent within diphenidine and becomes especially strong at higher dosages. This means that one should be sitting down before the onset (unless one is experienced) in case of falling over and injuring oneself.

Euphoria - This results in feelings of physical euphoria which range between mild pleasure to powerful all-encompassing bliss.

Decreased bodily weight - This creates the sensation that the body is floating and has become entirely weightless. This effect is strangely stimulating and encourages physical activities at low to moderate dosages by making the body feel light and effortless to move.

Dizziness - Although uncommon, some people report dizziness under the influence of diphenidine.

Nausea - It's worth noting that high dose diphenidine trips can sometimes result in nausea and vomiting at the peak of the trip. For most people, this is surprisingly not as unpleasant as they would initially expect due to the accompanying detachment from the physical senses.

Cognitive effects:

The general head space of diphenidine is often described as particularly euphoric and clear headed in comparison to that of DXM and Ketamine. The specific cognitive effects can be broken down into 8 separate subcomponents which are listed and described below:

Consciousness disconnection

Ego suppression, loss and death

Thought deceleration

Information processing suppression

Time distortion

Euphoria

Introspection

Deja-Vu

Conceptual thinking

Compulsive redosing

Visual effects:

Suppression:

This substance does not enhance visual stimuli; instead it tends to degrade and decrease visual aptitude in a variety of ways which generally includes:

Visual disconnection - This eventually results in the diphenidine's equivalent of the famous "K-hole" or more specifically, holes, space and voids alongside of structures.

Visual acuity suppression

Double vision - This component is prevalent at moderate to heavy dosages and makes reading impossible unless one closes an eye.

Pattern recognition suppression - This effect generally occurs at higher dosages and makes one unable to recognize and interpret perceivable visual data.

Distortions:

Diphenidine exhibits a full array of dissociative distortions and alterations in visual perception which generally includes:

Perspective distortions

Environmental cubism

Environmental orbism

Scenery slicing

Geometry:

The visual geometry found within diphenidine can be described as very dark and bland when compared to that of Ketamine or DXM and often consists of many tiny interlocking and woven lines. It does not extend beyond level 4 and can be comprehensively described through its variations as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicoloured in scheme, glossy in shading, soft in edges, small in size, slow in speed, smooth in motion, equal in rounded and angular corners, immersive in depth and consistent in intensity.

Hallucinatory states:

At high dosages, diphenidine can produce a full range of high level hallucinatory states in a fashion that that is less consistent and reproducible than that of many other commonly used psychedelics. These effects include:

Internal hallucinations (Autonomous entities, Settings, sceneries, and landscapes, Alterations in perspective and Scenarios and plots) - In comparison to other dissociatives, this effect can occur at heavy dosages but is considerably less common than the same effect found within psychedelics and deliriants. It can be comprehensively described through its variations as delirious in believability, fixed in style, equal in new experiences and memory replays in content, autonomous in controllability and solid in style.

Auditory effects:

The auditory effects are common in their occurrence and exhibit a range of effects which commonly includes:

Enhancements

Suppression

Distortions

Hallucinations

Physical health effects, potential addiction and tolerance:

The toxicity and long term health effects of recreational diphenidine use does not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because diphenidine is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried diphenidine within the psychonaut community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

There is a very strong tolerance build up with diphenidine which results in the need to consume increasingly large doses in order to achieve the same level of effects. This should reset to baseline after 1 - 2 weeks. There may well be some addictive potential but this is still unknown.

Tolerance may be mitigated via preparing the citrate salt by mixing the chemical with citric acid or lemon juice, which will aid in absorption and increase effects.

Legal issues:

Diphenidine is currently a legal grey area drug worldwide and is freely available through the use of online research chemical vendors. However, this does not guarantee anyone to be immune from legal prosecution should they be found in possession of this substance as the legality is likely to vary from country to country.

Conclusion:

In conclusion, diphenidine feels almost identical to MXE with only subtle differences. It is a powerful hallucinogen and just as capable of inducing deep states of detachment which rival that of the other more commonly used dissociatives.

This substance breakdown was written through collaboration between PsychonautWiki contributors Kaylee, PJosepherum, Josikins and Oscarette. The full article, including references, is available here.

21 notes · View notes

disregardeverythingisay-blog · 10 years

Text

Acid-Base DXM Extraction

DISCLAIMER: I do not encourage you to break the law and this guide is purely for informational purposes only. I am not responsible for your actions.

Theory:

This extraction uses acid-base reactions to extract the DXM HBr from cough syrup to its finished product, DXM salt in lemon juice. The basic ammonia converts the DXM to freebase. The Naptha is used as a nonpolar solvent to extract the DXM from the ammonia. Then, the citric acid binds with the freebase DXM to produce DXM hyrdocitrate, a DXM salt soluble in water. This extraction has a yield around 90-95% when followed carefully.

Materials:

DXM containing cough syrup. Cough syrup containing Dextromethorphan HBr ONLY is ideal. Syrups that also contain Guaifensin are acceptable. Do NOT use any syrups containing any other active ingredients, such as acetaminophen.

Ammonia (clear, unscented)

Naptha or Lighter Fluid

Citric Acid or Lemon Juice

Equipment:

Gallon sized unpleated zipper-seal bags

Pan and stove

A large glass bottle or container

Safety:

Use the correct cough syrup as using a cough syrup with active ingredients other than Dextromethorphan HBr is very dangerous.

Ammonia is flammable and irritating/caustic to the skin. It is caustic to the respiratory system if vapors are inhaled.

Naptha is a hazardous chemical with multiple safety concerns. It is extremely flammable. It is irritating to the eyes and skin. Vapors can be irritating to the respiratory system and in high concentrations can depress the CNS.

Do not use plastic containers with naptha (or, ideally, at all). Naptha can chemically attack and degrade many plastics.

Preparation:

If using citric acid, prepare a solution in water ahead of time. For each bottle of tussin, use 1.5 tablespoons of citric acid in 4 ounces of water. If using lighter fluid, be sure it evaporates without residue.

Procedure:

Add the cough syrup to the large glass bottle or sealable container.

Add in the same volume of ammonia (some excess is not a problem) and stir.

Tightly seal the container and shake vigorously for about 3 minutes.

Add in Naptha or lighter fluid, approximately 10% of the mixture in volume (a 1/2-1 inch layer) and shake for another 5 minutes.

Pour the liquid into a large gallon-sized zip lock container.

Let the mixture separate for 5-15 minutes. The resulting product should have two layers: the naptha layer (which the DXM is now bound to) on top and the ammonia-syrup layer on the bottom.

Cut a small hole in one corner of the zip-lock bag to drain. Dispose of the ammonia-syrup layer and collect the naptha/organic layer in a glass jar.

Optional: Adding 8 ounces of water to the organic naptha solution and allowing it to separate will minimize the amount of inactive ingredients (ammonia, cough syrup). Repeat this stage 1-3 times.

Now mix the solution with the pre-prepared citric acid solution or lemon juice. If using lemon juice, add an equal amount into the solvent layer.

Shake vigorously for at least 5 minutes.

Pour the solution into the gallon sized bag and allow it to separate, wait at least 45 minutes for the separation.

Now the citric acid/lemon juice layer is on the bottom with the naptha layer on top. Drain and collect the bottom layer and safely dispose of the top layer.

Boil the lemon juice for a few (5-10 minutes) to eliminate any left over organic solvents.

Allow to cool, this is your finished product.

Drink and enjoy!

Conclusion:

In conclusion, this simple article allows the masses to easily extract a powerful hallucinogenic substance from perfectly legal over the counter products containing DXM. This reduces the nausea associated with the compound and drastically increases potency.

The article was written and submitted by the PsychonautWiki contributor known as Kaylee. For more information and pictures of this extraction process, please see our full article here. For information on DXM and its effects, please click here.

#dxm #trip #extraction #robotripping #dissociative #psychonaut #fuckthesystem #i love you kaylee

222 notes · View notes

disregardeverythingisay-blog · 10 years

Text

25N-NBOMe, broken down and described

Dosage (oral) Threshold : 150 µg Light : 150 – 450 µg Common : 450 – 1000 µg Strong : 1000 – 2000 µg Heavy : 2000 µg

Duration (oral) Total duration : 4 - 6 hours Onset : 15 - 60 minutes Peak : 2 - 3 hours Come down : 2 - 3 hours After effects : 5 - 10 hours

Many drugs in the NBOMe series have been fatal at heavy doses.[1][2][3] It is strongly discouraged to take large amounts of this substance or to snort it.

25N-NBOMe (2C-N-NBOMe) is a derivative of the substituted phenethylamine psychedelic 2C-N which was discovered in 2004 by Ralf Heim at the Free University of Berlin and subsequently investigated by a team at Purdue University led by David Nichols.

25N-NBOMe has a notably shorter duration than the rest of the 25x-NBOMe series, with a total duration of 6 hours and a peak duration of 2 hours. It is moderately active at a 1mg dosage, and 2mg provides a strong/heavy trip. This substance is considerably less potent when compared to the more popular NBOMes such as 25B-NBOMe, 25I-NBOMe, and 25C-NBOMe, all of which lead to strong trips at 1mg+ doses.

In terms of its chemistry, 25N-NBOMe is a substituted phenethylamine with methoxy groups attached to carbons R2 and R5 as well as a nitrophenyl group attached to carbon R4. It differs from 2C-N structurally through a substitution on the amine (NH2) with a 2-methoxybenzyl (BOMe) group, which in turn increases potency about a hundred fold.

In terms of its pharmacology, 25N-NBOMe has efficacy at the 5-HT2A receptor where it is assumed to act as a partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive. There is insufficient scientific research to determine this compound's true nature as the pharmacological properties of 25N-NBOMe have not been described in the literature but only in anecdotal reports. 25N-NBOMe has been sold as a street drug and has only been described in the literature in terms of identification by forensic analysis.

Physical effects:

The physical effects of 25N-NBOMe can be broken down into seven components all of which progressively intensify proportional to dosage. These are described below and generally include:

Wakefulness

Stimulation - In terms of its effects on the energy levels of the tripper, 25N-NBOMe is quite stimulating, and leftover stimulation can linger up to 10 hours even after the trip subsides.

Vasoconstriction

Tactile enhancement - 25N-NBOMe increases tactile sensory input and feedback which intensifies tactile comfort and discomfort as well as pleasure and pain.

Bodily control enhancement - The drug increases muscle and bodily control.

Runny nose - 25N-NBOMe may cause a runny nose and increased mucus production in some users.

Nausea - Users (especially those prone to it) may experience nausea during the onset. The nausea will subside over the peak.

Cognitive effects:

The cognitive effects of 25N-NBOMe can be described as quite reminiscent to that of 25C-NBOMe's effects. They can be broken down into nine components all of which progressively intensify proportional to dosage. These are described below and generally include:

Time distortion

Introspection

Conceptual thinking

Thought connectivity

Feelings of self-design

Novelty enhancement

Cognitive euphoria

Laughter - There is an increased proneness to laughter and joy at moderate and heavier doses.

Disinhibition -

Visual effects:

Enhancements

Visual acuity enhancement

Colour enhancement

Pattern recognition enhancement

Distortions

Symmetrical texture repetition

3-Dimensional textures - At moderate and heavier doses, the textures will become 3-dimensional or appear to float/drift through space/air.

Drifting (Melting, Flowing, Breathing and morphing) - In comparison to other psychedelics, this effect can be described as highly detailed, slow and smooth in motion, static in appearance and unrealistic/cartoon-like in style.

Geometry

The visual geometry that is present throughout this trip is often described as similar in appearance to that of LSD. They can be comprehensively described as algorithmic in geometric style, intricate in complexity, fine and zoomed out in detail, fast and smooth in motion, structured in shape, colourful in scheme, glossy in colour, sharp around the edges and mostly rounded across their corners.

In terms of its behaviour, 25N-NBOMe’s geometry leads onto Level 8A visual geometry with Level 8B remaining so far unconfirmed within this substance. They also seem to consistently build up in visual intensity when the tripper stares at a central point. This eventually envelops the visual field and creates the sensation that the tripper has broken through into a continuously shifting geometric landscape or structure with a vast sense of immersive physical size attributed to it.

Hallucinatory states

Transformations

Internal hallucinations (Autonomous entities, Settings, sceneries, and landscapes, Alterations in perspective and Scenarios and plots) - 25N-NBOMe is capable of producing a full range of hallucinatory states within the level 1 - 3 range extremely consistently. Level 4 hallucinatory breakthroughs are reported, but very uncommon and inconsistent in comparison to other more commonly used psychedelics such as psilocin, 2C-E and DMT. This effect is more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and of no particular theme in their content or style.

Auditory effects:

The auditory effects of 25B-NBOMe are common in their occurrence and exhibit a full range of effects which commonly includes:

Enhancements

Distortions

Hallucinations

Physical health effects, potential addiction and tolerance:

The toxicity and long term health effects of recreational 25N-NBOMe use does not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 25N-NBOMe is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychedelic community who have tried 25N-NBOMe suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

Users should be very careful and consider that ingesting 2mg+ of NBOMe series chemicals have proven fatal in some cases. Although there are no reported fatalities caused by 25N-NBOMe at this time, it is a rare research chemical.

In terms of its addictive potential, 25N-NBOMe has not been studied formally, but due to its immediate tolerance build up, which lasts up to 2 - 3 weeks after the experience, it is difficult to use this substance compulsively.

Legal issues:

Brazil: The possession, production and sale is illegal.

USA: 25N-NBOMe is unscheduled in the United States. It may be considered an analog of 2C-N (which is a Schedule I drug under the Controlled Substances Act). As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analog Act.

UK: On 10 June 2014, all NBOMes became Class A drugs which means that they’re illegal to have, give away or sell. Possession could get one up to seven years in jail and/or an unlimited fine. Supplying someone else could result in a heavy jail time sentence between a minimum of eight years and a life sentence and/or an unlimited fine.

Conclusion:

This substance breakdown was written through collaboration between PsychonautWiki contributors Argent, Josikins and Oscarette. The full article, including references, is available here. Have a happy New Year! :)

21 notes · View notes

disregardeverythingisay-blog · 10 years

Text

2C-T-2, broken down and described

Dosage (oral) Threshold : 3 - 5 mg Light : 10 - 15 mg Common : 15 - 20 mg Strong : 20 - 30 mg Heavy : 25mg - 40mg

Duration (oral) Total duration : 5 - 10 hours Onset : 60 - 90 minutes Peak : 3 - 7 hours Come down : 1 - 2 hours After effects : 2 - 4 hours

Dosage (insufflated) Threshold : 1 - 3 mg Light : 2 - 5 mg Common : 5 - 15 mg Strong : 5 - 20 mg Heavy : 7 - 25mg+

Duration (insufflated) Total duration : 3 - 7 hours Onset : 5 - 15 minutes Peak : 2 - 4 hours Come down : 1 - 2 hours After effects : 1 - 2+ hours

2C-T-2 (2,5-dimethoxy-4-ethylthiophenethylamine) is a psychedelic phenethylamine of the 2C-x family. It was first synthesized by Alexander Shulgin in his book PiHKAL: A Chemical Love Story. This particular substance is part of the so-called "magical half-dozen" which refers to Shulgin's self-rated most important phenethylamine compounds, all of which except mescaline he developed and synthesized himself. They are found within the first book of PIHKAL, and are as follows: Mescaline, DOM, 2C-B, 2C-E, 2C-T-2 and 2C-T-7.

2C-T-2 is a highly dose sensitive psychedelic known for its strong visuals and very intense body load. Many reports also indicate that the physical effects are too severe for those who are not already experienced with psychedelics or suffer from pre-existing physical conditions, as it is known to cause powerful nausea and general bodily discomfort.

In terms of its chemistry, 2C-T-2 is a synthetic, substituted phenethylamine with methoxy groups attached to carbons R2 and R5 as well as a sulfide chain attached to carbon R4. 2C-T-2 is nearly identical in structure to 2C-T-7. The two molecules differ in the length of their sulfide chain; 2C-T-7 contains a propyl thioether group while 2C-T-2 contains a ethyl thioether group.

In terms of its pharmacology, the mechanism of action that produces 2C-T-2’s hallucinogenic and entheogenic effects has not been established in scientific literature, however its primary psychedelic effects are more than likely a result from its efficacy at the 5-HT2A receptor as a partial agonist. This mechanism of action is shared by many other psychedelic phenethylamines and tryptamines.

Athough no established scientific experiments have been preformed to establish MAO-A inbihition of 2C-T-2, phenethylamine derivatives substituted with an alkylthio group at the 4 position (such as 2C-T-7, 4-MTA, and the 2,5-desmethoxy derivative of 2C-T-7) are known to act as selective monoamine oxidase A inhibitors. Therefore, this substance may likewise have MAOI effects.

Physical Effects:

The physical effects of 2C-T-2 can be broken down into eight components all of which progressively intensify proportional to dosage. These are described below and generally include:

Spontaneous tactile sensations - The body high of 2C-T-2 can be described as very intense and uncomfortable in comparison to 2C-E or 2C-B. In high doses, it's capable of causing painful cramping. It is similar yet distinct from the body high experienced on 2C-T-7, but is considered much more unpleasant. The sensation itself can be described as intense and may manifest itself in the form of a continuously shifting tingling sensation that travels up and down the body in spontaneous waves.

Stimulation - In terms of its effects on the physical energy levels of the tripper, 2C-T-2 is usually considered to be very energetic and stimulating in a fashion that is quite comparable to that of other phenethylamines such as 2C-B, 2C-E and 2C-P.

Bodily control enhancement - Although this component is capable of manifesting itself in a distinct and noticeable fashion for most users, it does not generally seem to be as apparent or intense as the same component found within LSD and 2C-B.

Tactile enhancement

Nausea - Extreme nausea is commonly reported when consumed in moderate to high dosages and either passes once the tripper has vomited or gradually fades by itself as the peak sets in. It can be described as very painful and violent in comparison to 2C-T-7 or 2C-E.

Stomach cramps

Vasoconstriction

Temperature regulation loss

Cognitive Effects:

The head space of 2C-T-2 is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.

The total sum of these cognitive components regardless of the setting generally includes:

Current mind state enhancement

Thought acceleration

Feelings of fascination, importance and awe

Time distortion

Analysis enhancement - This effect is consistent in its manifestation and is outrospection dominant.

Personal bias suppression

Conceptual thinking

Ego suppression, loss and death

Thought loops

Feelings of interdependent opposites

Delusions

Unity and interconnectedness

Visual effects:

Enhancements

2C-T-2 presents a full and complete array of possible visual enhancements which generally includes:

Visual acuity enhancement

Colour enhancement

Pattern recognition enhancement

Distortions

2C-T-2 presents a full and complete array of possible visual distortions which generally includes:

Tracers

After images

Symmetrical texture repetition

Colour shifting

Scenery slicing

Geometry

The visual geometry that is present throughout this trip can be described as somewhat similar in appearance to that of Ayahuasca, Psilocin, and 4-ACO-DMT, with mystical and shamanic undertones which combine with synthetic digital undertones reminiscent of LSD or 2C-E. 2C-T-2's geometry can be comprehensively described through its variations as intricate in complexity, abstract in form, organic but somewhat synthetic in style, structured in organization, brightly lit and multicoloured in scheme, glossy in shading, rounded in edges, large in size, fast in speed, smooth in motion, mostly angular in corners, immersive in depth and consistent in intensity. The visuals have a contradictory "natural" and "synthetic" feel to them which is reminiscent of DOC or 2C-P. Higher dosages are more likely to result in states of Level 8B visual geometry, but may also lead into Level 8A visual geometry (as with 2C-T-7).

Hallucinatory states

2C-T-2 produces a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. This holds particularly true in comparison to other substances within the phenethylamine family. These effects include:

Transformations

External hallucinations - In comparison to other psychedelics such as Ayahuasca, 2C-T-2 is very high in external hallucinations. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact manifested as dense solidified geometric matter or physical objects of imagined concepts. They are more common within dark environments and can be described as external in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

Internal hallucinations - In comparison to other psychedelics such as LSD, 2C-T-2 is very high in hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

Auditory effects:

The auditory effects of 2C-T-2 are more common in their occurrence than many more commonly used psychedelics and exhibit a full range of effects which commonly includes:

Enhancements

Distortions

Hallucinations

Physical Health Effects, Potential Addiction and Tolerance:

The toxicity and long term health effects of recreational 2C-T-2 use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 2C-T-2 is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried 2C-T-2 within the psychedelic community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

There is no current data for the LD50 of 2C-T-2, but it is thought to be high.

2C-T-2 does not seem to be physically addictive and many users experience a self-regulating quality, especially due to the physical manifestations of its effects. There seems to be a tolerance build up when used consecutively multiple days in a row which requires one to double their dosage each time to achieve the same effects.

If 2C-T-2 does have MAOI effects, this could indicate that 2C-T-2 is more likely to induce serotonin syndrome, especially at high dosages, than other serotonergic hallucinogens. This may make it dangerous to combine with certain substances such as MDMA, AMT, Ayahuasca or any substance which releases neurotransmitters such serotonin or those with similar pharmacological effects.

Legal issues:

UK: 2C-T-2 is a Class A substance making it illegal to possess, manufacture, or import.

USA: 2C-T-2 is a Schedule 1 drug in the USA, making it illegal to possess, manufacture, or import.

Australia: 2C-T-2 is illegal in Australia as of 2005.

Belgium: 2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004.

Brazil: 2C-T-2 is illegal in Brazil as of Feb 18, 2014.

Denmark: 2C-T-2 was added to category B of the controlled substances list on August 23, 2003.

E.U.: EU Council published an order on Dec 6 2003, asking all member states to control 2C-I, 2C-T-2, 2C-T-7, and TMA-2.

Germany: The drug is on list I / highest level of control, making it unable to be prescribed, manufactured, or possessed as of Oct 7, 1998.

Italy: 2C-T-2 was added to the "Tabella 1" in a Jan 11, 2005 Ministry of Health statement.

Japan: 2C-T-2 is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell

Netherlands: It was classified as an unregistered pharmaceutical as of April 12, 1999. Unlicensed manufacture, sale, import, trade and possession of this substance can be prosecuted.

Conclusion:

In conclusion, 2C-T-2 offers incredible depth and a full spectrum of deep psychedelic effects with a cognitive head space that's closer to a tryptamine psychedelic than many other phenylethylamines. The nausea and physical body load is very intense in proportion to 2C-T-7 and other phenylethylamines, which may be very undesirable to some, however it is still completely worthy of its position within the magical half dozen.

This substance breakdown was written in collaboration with PsychonautWiki admin Cocoanatta. For a more detailed breakdown please click the here.

16 notes · View notes

disregardeverythingisay-blog · 10 years

Text

bk-MDMA, broken down and described

Dosage (oral):

Threshold : 60mg Light : 100 - 150mg Common : 150 - 250mg Strong : 200 - 300mg

Duration (oral):

Total : 3 - 5 hours Onset : 20 - 60 minutes Peak : 60 - 90 minutes Offset : 60 - 120 minutes After effects : 1 - 6 hours

Methylone (also known as M1, 3,4-methylenedioxy-N-methylcathinone, MDMC and bk-MDMA) is an entactogen and stimulant of the phenethylamine, amphetamine and cathinone classes. It was first synthesized by chemists Peyton Jacob III and Alexander Shulgin in 1996 for potential use as an antidepressant.

This compound is often used as a substitute for MDMA due to its similar range of subjective effects. However, in spite of behavioral and pharmacological similarities between methylone and MDMA, the observed subjective effects of both drugs are not completely identical. Alexander Shulgin wrote of the former:

"Methylone has almost the same potency of MDMA, but it does not produce the same effects. It has an almost antidepressant action, pleasant and positive, but not the unique magic of MDMA."

"Methylone" is also a trademarked brand name for an injectable form of methylprednisolone, a corticosteroid hormone used to treat arthritis and severe allergic reactions; hence, methylone may be confused with it.

In terms of its chemistry, 3,4-methylenedioxy-N-methylamphetamine is part of the phenethylamine, cathinone and amphetamine families. There is a methylenedioxy ring attached to carbons R3 and R4, as well as methyl chains at Rα and RN. Methylone is a close structural analog of MDMA, differing by the addition of a β-ketone group attached to the beta position of the amine chain.

In terms of its pharmacology, methylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These are the neurotransmitters in charge of pleasure, motivation and focus. This is done by inhibiting the reuptake and reabsorption of the neurotransmitters after they have performed their function of transmitting a neural impulse, essentially allowing them to accumulate and be reused, causing physically stimulating and euphoric effects.

In comparison to MDMA, it has approximately 3x lower affinity for the serotonin transporter, while its affinity for the norepinephrine and dopamine transporters is similar. Notably, methylone's affinity for the vesicular monoamine transporter 2 (VMAT2) is about 13x lower than that of MDMA. The results of these differences in pharmacology relative to MDMA are that methylone is less potent in terms of dose, has more balanced catecholaminergic effects relative to serotonergic, and behaves more like a reuptake inhibitor like methylphenidate than a releaser like amphetamine; however, methylone still has relatively robust releasing capabilities.

Physical effects:

The physical effects of methylone can be broken down into seven components all of which progressively intensify proportional to dosage. These are described below and generally include:

Spontaneous tactile sensations - The "body high" of methylone can be described as a moderate to extreme euphoric tingling sensation that encompasses the entire body. It is capable of becoming overwhelmingly pleasurable at higher dosages. This sensation maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.

Stimulation - In terms of its effects on the user's physical energy levels, methylone is commonly considered to be extremely stimulating and energetic. This encourages activities such as running, climbing and dancing in a way that makes methylone a popular choice for musical events such as festivals and raves. The particular style of stimulation which methylone presents can be described as forced. This means that at higher dosages, it becomes difficult or impossible to keep still as jaw clenching, involuntarily bodily shakes, and vibrations become present, resulting in an extreme unsteadiness of the hands and a general lack of motor control.

Vibrating vision - At high dosages, a person's eyeballs may even begin to spontaneously wiggle back and forth in a rapid motion, causing the vision to become blurry and temporarily out of focus-- a condition known as nystagmus.

Dehydration - Feelings of dry mouth and dehydration are a universal experience with methylone; this effect is a product of an increased heart rate and an extreme motivation to engage in strenuous physical activities. While it is important to avoid becoming dehydrated, especially when out dancing in a hot environment, there have been a number of users suffering from water intoxication through over-drinking so it is advised that users simply sip at water and never over-drink.

Difficulty urinating - Higher doses of methylone result in an overall difficulty when it comes to urination. This is an effect that is completely temporary and harmless, due to methylone’s promotion of the release of anti-diuretic hormone (ADH). ADH is responsible for regulating urination. This effect can be lessened by simply relaxing, but can be significantly relieved by placing a hot flannel over the genitals to warm them up and encourage blood flow.

Loss of temperature regulation

Tactile enhancement

Cognitive effects:

The cognitive effects of methylone can be broken down into six components all of which progressively intensify proportional to dosage. The general head space of methylone is described by many as one of extreme mental stimulation, feelings of love or empathy and powerful euphoria. It contains a large number of typical psychedelic, entactogenic and stimulant cognitive effects.

The most prominent of these cognitive effects generally include:

Euphoria - Strong emotional euphoria and feelings of happiness are present within methylone and are likely a direct result of serotonin and dopamine release. In comparison to MDMA, it is closer in effects to that of the euphoria felt within amphetamine and mephedrone.

Empathy, love and sociability enhancement - Although distinct and powerful in its effects, this particular feeling is less pronounced and therapeutic when compared to that of MDMA. It can be described as less forceful and more internal in its manifestation, resulting in feelings of love and empathy that are not necessarily felt as essential to express to others.

Time distortion - Strong feelings of time compression are common within methylone and speed up the experience of time quite noticeably.

Unity and interconnectedness - Experiences of unity, oneness and interconnectedness between levels 2 - 3 are common within methylone. This component most consistently manifests itself at high dosages within large crowds at raves and musical events in the form of "becoming one with the crowd."

Thought acceleration

Mindfulness

Physical Health Effects, Potential Addiction and Tolerance:

The toxicity and long term health effects of recreational methylone use does not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because methylone is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried methylone suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

Tolerance develops rapidly with repeated usage, so periods of extended use require increasing doses of the drug in order to achieve the same effect. Addiction is a serious risk with heavy recreational use of any stimulant where compulsive redosing is common.

Legal Issues:

Netherlands: In the Netherlands, methylone is covered under the medicine act. Because methylone is not registered officially, as such, it is forbidden to trade in methylone.

New Zealand: In New Zealand, although methylone is not explicitly scheduled and falls outside the strict definitions of an "amphetamine analogue" in the Misuse of Drugs Act, it is considered to be "substantially similar" to methcathinone and is thus considered by law enforcement authorities to be a Class C illegal drug.

United Kingdom: In the UK, methylone has been illegal since the 16/04/2010 revision of the misuse of drugs act.

Sweden: Methylone has been listed as a schedule I narcotic in Sweden as of Oct 1 of 2010.

Canada: Although not listed as a Schedule 1 substance, Health Canada reports that methylone falls under the scheduling as an analogue of amphetamine. However, Methylone bears the exact chemical difference between amphetamine and cathinone; cathinone is listed as not being an analogue of amphetamine leading to imply that methylone is unscheduled in Canada.

United States: As of October 21, 2011 the DEA has issued an emergency ban on methylone. It is illegal to possess and distribute.

Conclusion:

In conclusion, although bk-MDMA is similar to MDMA in high doses, its euphoria is directed inwards rather than forcing the user to project their empathy and love onto others. The dosage is much higher than MDMA in comparison, and it's a more complex experience due to its different receptor efficacies; there is not simply serotonin happiness, but dirty stimulation too.

This substance breakdown was written through collaboration between PsychonautWiki contributors Pjosepherum, Josikins and Oscarette. The full article, including references, is available here.

46 notes · View notes

disregardeverythingisay-blog · 10 years

Text

5-MeO-DMT, broken down and described

Dosage (smoked) Threshold : 1 - 2 mg Light : 2 - 5 mg Common : 5 - 10 mg Strong : 10 - 20 mg Heavy : 20mg +

Duration (smoked) Total duration : 30 minutes Onset : 0 - 1 mins Peak : 1 - 15 minutes Come down : 3 - 5 mins After effects : 15 - 60 mins

Dosage (insufflated) Threshold : 3 - 5 mg Light : 5 - 10 mg Common : 8 - 15 mg Strong : 10 - 25 mg Heavy : 25mg+

Duration (insufflated) Total duration : 2 - 3 hours Onset : 1 - 10 mins Peak : 30 - 60 mins Come down : 30 - 60 mins After effects : 1 - 3 hrs

5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine) is a powerful psychedelic tryptamine. It is found in a wide variety of plant species, and a single psychoactive toad species. Like its close relatives DMT and bufotenin (5-HO-DMT), it has been used as an entheogen by South American shamans for thousands of years. In modern times, however, it is primarily acquired in its pure form through the use of online research chemical vendors.

When used as a drug in its purified form, 5-MeO-DMT is vaporized, insufflated, or injected and is active at a dose of as little as 2 mg. 5-MeO-DMT is active orally when taken with an MAOI, but according to numerous reports this combination is extremely unpleasant and has a strong body load.

In terms of its chemistry, 5-MeO-DMT is made up of a tryptamine backbone, with a methoxy group substituted onto carbon R5 and two methyl groups substituted onto the nitrogen RN1 and RN2. 5-MeO-DMT is a methoxy derivative of DMT. It is also the O-methyl analogue of bufotenin (5-HO-DMT) and occurs in many organisms alongside of this compound.

In terms of its pharmacology, 5-Meo-DMT's psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. Specifically, this molecule shows high affinity for the 5-HT2 and 5-HT1A subtypes. Additional mechanisms of action such as reuptake inhibition of neurotransmitters such as serotonin, noradrenaline and dopamine are involved also.This can result in 5-MeO-DMT becoming dangerously toxic when combined with MAOIs, RIMAs, SSRIs stimulants or any substance which acts as a releasing agent or reuptake inhibitor of neurotransmitters.

5-MeO-DMT is O-demethylated by polymorphic cytochrome P450 2D6 (CYP2D6) to an active metabolite, bufotenin.

However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Physical Effects:

The physical effects of 5-MeO-DMT can be broken down into ten components all of which progressively intensify proportional to dosage. In comparison to its often relatively mild accompanying cognitive and visual effects, 5-MeO-DMT seems to have by far the most proportionally intense and overwhelming physical sensations found within the known psychedelic experience. These individual components are complex, overwhelming and equally capable of being interpreted as either extremely pleasurable or uncomfortable.

Enhancement of tactile sensations - This particular component is perhaps the most overwhelming sensation within the entirety of the 5-MeO-DMT experience. It increases the intensity of tactile sensations to such an overwhelming extent that it induces a sustained and repeatable full body orgasm within every nerve ending across the entire body. The experience of this results in the perception of having a difficulty sustaining the act of breathing. It is worth noting, however, that this is not a genuine or dangerous experience of respiratory depression and is perfectly safe.

Physical euphoria

Nausea

Increased bodily control

Loss of motor control

Bodily pressures

Skin flushing

Changes in gravity

Loss of temperature regulation

Increased bodily weight

Cognitive Effects:

The most prominent of 5-MeO-DMT's cognitive effects generally include:

Current mind state enhancement

Mindfulness

Conceptual thinking

Thought connectivity

Anxiety

Time distortion

Direct communication with the subconscious

States of unity and interconnectedness

Ego suppression, loss and death

Delusions

Amnesia

Visual effects:

The visual effects of 5-MeO-DMT can be broken down into five components all of which progressively intensify proportional to dosage. In comparison to its consistently overwhelming and intense accompanying cognitive and physical effects, 5-MeO-DMT seems to have some of the most proportionally underwhelming visual effects found within the known psychedelic experience.

Visual acuity enhancement and Visual acuity suppression - 5-MeO-DMT is equally capable of both decreasing and increasing visual acuity. The outcome of which effect will manifest seems to be chosen almost entirely at random and is largely setting dependent.

Colour enhancement

Colour shifting

Drifting (Morphing, Breathing, Melting, Flowing) - In comparison to other psychedelics, this effect can be described as identical to DMT in its style, highly detailed, slow and smooth in motion and static in appearance.

Geometry - The visual geometry that is present throughout this trip does not usually occur and never extends beyond level 7 at its highest state. It is very similar to DMT although significantly smaller in size and more likely to manifest in darkness or without distractions. In terms of appearance, it can be comprehensively described through its variations as intricate in complexity, abstract in form, equally organic and digital in feel, structured in organization, brightly lit, multicoloured in scheme, glossy in shading, equal in sharp and soft edges, small in size, fast in speed, smooth in motion, equal in rounded and angular corners, immersive in depth and consistent in its intensity.

Auditory effects:

The auditory effects of 5-MeO-DMT are common in their occurrence and exhibit a full range of effects which generally include:

Enhancements

Distortions

Hallucinations

Natural sources:

Colorado River toad: The Colorado River toad (Incilius alvarius), also known as the Sonoran Desert toad, is a psychoactive toad found in northern Mexico and the southwestern United States. Its skin and venom contain 5-MeO-DMT and bufotenin.

The toad's primary defense system are glands that produce a poison that may be potent enough to kill a grown dog. These parotoid glands also produce the 5-MeO-DMT and bufotenin for which the toad is known. Fresh venom can easily be collected from these glands without harm to the toad. To do this, obtain a flat glass plate or any other smooth, nonporous surface of at least 12-inches square and hold the toad in front of the plate (which is fixed in a vertical position). When the desert toad is stroked near the parotid glands in the neck region, there is a squirting out of this venom. When it is allowed to dry on a hard surface it takes on the texture of rubber cement. It contains up to 15% 5-MeO-DMT, as well as N-methyl-5-methoxytryptamine, 5-MeO-NMT and Bufotenine, which have their own entries. In this manner, the venom can be collected on the glass plate, free of dirt and liquid released when the toad is handled.

Physical Health Effects, Potential Addiction and Tolerance:

The toxicity and long term health effects of recreational 5-MeO-DMT use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. Anecdotal evidence from people within the psychedelic community who have tried 5-MeO-DMT suggests that although physically intense, this substance is well tolerated and physically benign just like other tryptamines. There are no known negative health effects attributed to trying this substance at low or heavy dosages and it has a long history of usage dating back thousands of years.

Deaths from 5-MeO-DMT are rare but, as a powerful monoamine reuptake inhibitor, injury can occur when excessive doses are taken or when taken with drugs such as MAOIs, RIMAs, stimulants and any substance which act as a releasing agent or reuptake inhibitor of neurotransmitters such as serotonin and dopamine. This has resulted in well documented deaths that are easily avoidable and could have been otherwise prevented.

There is a strong tolerance gained after a single dosage of this compound. This diminishes effects greatly if one tries to redose but returns to base line levels within 24 hours.

Legal issues:

Denmark: As of December 1, 2004, 5-MeO-DMT was legally restricted to "medical or scientific purposes".

Gemany: As of December 1, 2004, 5-MeO-DMT was legally restricted to "medical or scientific purposes".

Greece: 5-MeO-DMT became a controlled substance in Greece on February 18, 2003 [EU Legal Database].

New Zealand: 5-MeO-DMT is Schedule I (Class A) in New Zealand.

Sweden: Sveriges riksdags health ministry Statens folkhälsoinstitut classified 5-MeO-DMT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated "Act on the Prohibition of Certain Goods Dangerous to Health") as of Oct 1, 2004, in their regulation SFS 2004:696 listed as 5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT), making it illegal to sell or possess.

Switzerland: 5-MeO-DMT is Schedule I in Switzerland.

Romania: 5-MeO-DMT is illegal in Romania since February 2010.

USA: 5-MeO-DMT was added to Schedule I, effective January 19, 2011. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license.

Conclusion:

In conclusion, 5-MeO-DMT is an A-Typical psychedelic which although interesting, remains very consistent and repetitive in comparison to other tryptamines such as DMT itself. It is worth trying for the sheer physical intensity and euphoria of it but I would not recommend this substance to anybody who is looking to experience genuine psychedelia.

This substance breakdown was written through collaboration between PsychonautWiki contributors Pjosepherum, Josikins and Oscarette. The full article is available here.

#5meodmt #5-meo-dmt #dmt #psychedelics #psychedelic #research chemicals #psychonaut #i am so high lol

87 notes · View notes

disregardeverythingisay-blog · 10 years

Text

☯ ♡ ∞ ♡ ☯

Today marks three years since the start of DEIS. We would like to thank each and every one of you for the balls you have tripped, your support and your contributions. Much love to all of you!!! ♡ ♡ ♡ (• ε •) Sorry for the lack of new content around here recently, you can be expecting many posts and updates very soon. In the mean time, for frequent updates, an active community and a far superior website, please visit our ongoing project www.PsychonautWiki.org

#the world is a beautiful place and i am no longer afraid to die

28 notes · View notes

disregardeverythingisay-blog · 10 years

Text

MDAI, broken down and described

Dosage (oral):

Threshold : 20 - 30mg Light : 60 - 100mg Common : 100 - 175mg Strong : 175 - 300+mg

Duration (oral): Onset : 20 - 70 minutes Peak : 3 - 5 hours Coming down : 3 - 4 hours After effects : 24 hours

MDAI (5,6-Methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) which produces entactogen effects in humans similar to that of MDMA.

In terms of its chemistry, the chemical structure of MDAI is indirectly derived from that of the illicit drug MDA, but the alpha-methyl group of the alkylamino amphetamine side chain has been bound back to the benzene nucleus to form an indane ring system. This changes its pharmacological properties substantially.

In terms of its pharmacology, MDAI has been shown to inhibit the reuptake of serotonin, dopamine, and norepinephrine. This demonstrates that MDAI has selective affinity for the serotonin receptor. Studies show that the brains of animals treated with MDAI have greater extracellular concentrations of monoamine neural transmitters, most significantly serotonin. This result indicates that MDAI is a potent releaser of serotonin while effectively inhibiting the reuptake of serotonin. For comparison, MDAI is similar in potency with releasing serotonin to MDA but significantly less potent than MDMA.

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects may rarely if ever occur all at once but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical Effects:

The physical effects of MDAI can be broken down into seven components all of which progressively intensify proportional to dosage. These are described below and generally include:

Euphoria

Enhancement of touch

Sedation - The biggest difference between MDAI and MDMA is that due to a comparative lack of dopamine reuptake inhibition, MDAI primarily results in moderate sedation and therefore discourages physical activities such as running, dancing or climbing.

Spontaneous tactile sensations - The "body high" of MDAI can be described as a moderate to extreme euphoric, soft and warm tingling sensation that encompasses the entire body. It is capable of becoming overwhelmingly pleasurable at higher dosages. This sensation maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.

Dehydration - Feelings of dry mouth and dehydration are a universal experience with MDAI; this effect is a product of an increased heart rate and an extreme motivation to engage in strenuous physical activities. While it is important to avoid becoming dehydrated, especially when out dancing in a hot environment, there have been a number of users suffering from water intoxication through over-drinking so it is advised that users simply sip at water and never over-drink.

Cognitive Effects:

The cognitive effects of MDAI can be broken down into four components all of which progressively intensify proportional to dosage. The general head space of MDAI is described by many as one of euphoria and feelings of love or empathy. It contains a number of typical entactogenic cognitive effects.

The most prominent of these cognitive effects generally include:

Euphoria - Strong emotional euphoria and feelings of happiness are present within MDAI and are a direct result of serotonin and dopamine release.

Increased empathy, love and sociability - This particular effect is equally as pronounced, powerful and therapeutic as that of MDMA or 2C-B. It is the most obvious and noticeable effect within any MDAI experience and dominates the head space.

Acceleration of thought

Mindfulness

Visual effects:

The visual effects of MDAI only occur at higher dosages and are subtly psychedelic. These generally include:

Increased visual acuity

Enhancement of colour

Tracers

Physical Health Effects, Potential Addiction and Tolerance:

MDAI and other similar drugs have been widely used in scientific research, as they are able to replicate many of the effects of MDMA but without causing the neurotoxicity which may be associated with MDMA and some related drugs. No tests have been performed on cardiovascular toxicity.

There is currently no scientific data on the lethal dosage of MDAI within human beings but it is thought to be high in comparison to its active dosage. Due to its action as a serotonin reuptake inhibitor, overdoses of this substance would likely result in acute or even fatal serotonin syndrome.

The tolerance to MDAI builds up with repeated usage in much the same way that MDMA does. There does not seem to be any addictive potential but long term usage could potentially lead onto it.

Legal issues:

MDAI is currently a legal grey area world wide and freely available through the use of online research chemical vendors. This does not mean that you are guaranteed to be immune from legal prosecution should you be found in possession of this substance as it is likely to vary from country to country.

Conclusion:

In conclusion, MDAI is an extremely interesting alternative to MDMA due to its lack of neurotoxic effects and minimal dopamine reuptake inhibition. I would suggest this compound to anybody who wishes to experience the profound therapeutic entactogenic effects of MDMA without the stimulation or neurotoxicity. I would recommend the use of 5-HTP serotonin supplements the day after heavy MDAI usage to further mitigate its unlikely adverse effects .

This substance breakdown was written through collaboration between PsychonautWiki administrators Josikins and Oscarette. The full article is available here.

23 notes · View notes

disregardeverythingisay-blog · 10 years

Text

4-AcO-MET, broken down and described

Dosage (oral):

Threshold : 5 - 10mg Light : 10 - 20mg Common : 20 - 30mg Strong : 30 - 40mg Heavy : 40mg+

Duration (oral):

Total Duration : 4 - 6 hours Onset : 20 - 60 minutes Peak : 1 - 2 hours Coming down : 2 - 4 hours After effects : 1 - 5 hours

4-Acetoxy-MET (4-Acetoxy-N-methyl-N-ethyltryptamine, metacetin or 4-AcO-MET) is a psychedelic tryptamine thought to be a serotonergic psychedelic similar to 4-AcO-DMT, LSD and DMT. Its molecular structure and pharmacological effects resemble those of the tryptamine psilocin which is the primary psychoactive chemical in magic mushrooms.

In terms of its chemistry, 4-AcO-MET is the acetate ester of 4-HO-MET. It is a substituted tryptamine with an acetoxy group at the 4 position of the cyclohexane ring, an ethyl chain and a methyl chain on the nitrogen position.

It is hypothesized that this compound is quickly hydrolyzed into the free phenolic 4-HO-MET, although human studies concerning the metabolic fate of this drug are lacking. This would explain a somewhat similar experience in their subjective effects. This is similar to how 4-AcO-DMT is thought to be deacetylated to 4-HO-DMT during first pass metabolism and subsequent passes through the liver.

In terms of its pharmacology, 4-AcO-MET's psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

4-AcO-MET is commonly sold as a research chemical through the use of online vendors. In terms of its effects, it can be vaguely described as somewhat more synthetic in feel to that of other tryptamines but with a shorter duration.

Physical Effects:

The physical effects of 4-AcO-MET can be broken down into three components all of which progressively intensify proportional to dosage. These are described below and generally include:

Spontaneous tactile sensations - The "body high" of 4-AcO-MET can be described as a pleasurable, warm, soft and all-encompassing tingling sensation. This maintains a consistent presence that steadily rises with the onset and hits its limit once the peak has been reached.

Sedation - In terms of its effects on the physical energy levels of the tripper, 4-AcO-MET is considered by most to be relaxing, stoning and mildly sedating. This sense of sedation is often accompanied by compulsive yawning.

Nausea

Cognitive Effects:

The cognitive effects of 4-AcO-MET are described by many as somewhat relaxing, yet face-paced in style with similarities to psychedelics such as LSD or 2C-B which tend to be cognitively energetic and stimulating. The drug contains a large number of typical and unique psychedelic cognitive effects.

The most prominent of these typical effects generally include:

Enhancement of current mind state

Connectivity of thought

Acceleration of thought

Feelings of fascination, importance and awe

Time distortion

Outrospection

Thought loops

Removal of cultural filter

Conceptual thinking

Direct communication with the subconscious

Ego suppression, loss and death

Feelings of interdependent opposites

Delusions

States of unity and interconnectedness

Visual effects:

Enhancements

4-AcO-MET presents a full and complete array of possible visual enhancements which generally includes:

Increased visual acuity

Enhancement of colour

Enhanced pattern recognition

Distortions

As for visual distortions and alterations, the effects experienced are detailed below:

Drifting (Melting, Flowing, Breathing and morphing) - In comparison to other psychedelics, this effect can be described as highly detailed, cartooon-like in style, slow and smooth in motion and static in appearance.

Tracers

After images

Texture repetition

Colour shifting

Scenery slicing

Geometry

The visual geometry that is present throughout this trip can be described as somewhat similar in appearance to that of Psilocin, 4-AcO-DMT and 4-HO-MiPT but with far stronger synthetic digital undertones reminiscent of LSD or 2C-B. 4-AcO-MET can be comprehensively described through its variations as intricate in complexity, abstract in form, equally synthetic and organic in style, structured in organization, extremely brightly lit and multicoloured in scheme, glossy in shading, sharp in edges, large in size, fast in speed, smooth in motion, angular in corners, unimmersive in depth and consistent in intensity. The visuals have a contradictory "natural" and "synthetic" feel to them which is reminiscent of both LSD and and Psilocybin. Higher dosages are significantly more likely to result in states of Level 8A visual geometry over Level 8B.

Hallucinatory States

4-AcO-MET and its various other forms produce a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. These effects generally include:

Transformations

Internal hallucinations (Autonomous entities, Settings, sceneries, and landscapes, Alterations in perspective and Scenarios and plots) - This effect is very consistent in dark environments at appropriately high dosages. They can be comprehensively described through their variations as lucid in believability, interactive in style, new experiences in content, autonomous in controllability, geometry-based in style and almost exclusively of a religious, spiritual, mystical, science fiction or transcendental nature in overall theme.

Auditory Effects:

The auditory effects of 4-AcO-MET are common in their occurrence and exhibit a full range of effects which commonly include:

Enhancements

Distortions

Hallucinations

Physical Health Effects, Potential Addiction and Tolerance:

The toxicity and long term health effects of recreational 4-AcO-MET use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 4-AcO-MET is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried 4-AcO-MET within the psychonaut community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

There is no current data for the LD50 of 4-AcO-MET, but it is thought to be high.

4-AcO-MET does not seem to be physically addictive and many users experience a self-regulating quality. There seems to be a tolerance build up when used consecutively multiple days in a row which requires one to double their dosage each time to achieve the same effects.

Legal issues:

USA: 4-Acetoxy-MET is unscheduled in the United States, but the possession and sale of 4-Acetoxy-MET could possibly be prosecuted under the Federal Analog Act if intent to consume can be proven because of its structural similarities to psilocin.

Conclusion:

4-AcO-MET induced a trip which was distinctively different from that of other more commonly used research chemicals that I have tried. The colourful, digital and synthetic geometry was in sharp contrast to that of 4-AcO-DMT, psilocybin and ayahuasca. This combined with its shorter duration and equally insightful headspace made for a therapeutic and recreational experience somewhat halfway between that of mushrooms and LSD.

This substance breakdown was written through collaboration between PsychonautWiki contributors Josikins and Oscarette. The full article is available here.

#4ACOMET #4-ACO-MET #DMT #psychedelics #i love you all #trippy #psychonaut #psychonautics #psychonauts

30 notes · View notes